Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Targeting pro-senescence mitogen activated protein kinase (Mapk) enzymes with bioactive natural compounds.

Cano M, Guerrero-Castilla A, Nabavi SM, Ayala A, Argüelles S.

Food Chem Toxicol. 2019 Jun 12. pii: S0278-6915(19)30319-9. doi: 10.1016/j.fct.2019.05.052. [Epub ahead of print]

PMID:
31201898
2.

Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.

Smeriglio A, Denaro M, Mastracci L, Grillo F, Cornara L, Shirooie S, Nabavi SM, Trombetta D.

Daru. 2019 May 26. doi: 10.1007/s40199-019-00274-3. [Epub ahead of print]

3.

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, Sychrová A, Barreca D, Ziberna L, Mahomoodally MF, Zengin G, Xu S, Nabavi SM, Shen AZ.

Theranostics. 2019 Mar 16;9(7):1923-1951. doi: 10.7150/thno.30787. eCollection 2019. Review.

4.

Antidepressive effects of a chemically characterized maqui berry extract (Aristotelia chilensis (molina) stuntz) in a mouse model of Post-stroke depression.

Di Lorenzo A, Sobolev AP, Nabavi SF, Sureda A, Moghaddam AH, Khanjani S, Di Giovanni C, Xiao J, Shirooie S, Tsetegho Sokeng AJ, Baldi A, Mannina L, Nabavi SM, Daglia M.

Food Chem Toxicol. 2019 Jul;129:434-443. doi: 10.1016/j.fct.2019.04.023. Epub 2019 Apr 22.

PMID:
31022478
5.

Bioactive peptides and proteins as alternative antiplatelet drugs.

Rengasamy KRR, Khan H, Ahmad I, Lobine D, Mahomoodally F, Suroowan S, Hassan STS, Xu S, Patel S, Daglia M, Nabavi SM, Pandian SK.

Med Res Rev. 2019 Apr 22. doi: 10.1002/med.21579. [Epub ahead of print] Review.

PMID:
31006878
6.

Novel therapeutic strategies for stroke: The role of autophagy.

Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S.

Crit Rev Clin Lab Sci. 2019 May;56(3):182-199. doi: 10.1080/10408363.2019.1575333. Epub 2019 Mar 1.

PMID:
30821184
7.

Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.

Hajialyani M, Hosein Farzaei M, Echeverría J, Nabavi SM, Uriarte E, Sobarzo-Sánchez E.

Molecules. 2019 Feb 12;24(3). pii: E648. doi: 10.3390/molecules24030648. Review.

8.

Curcumin, the golden spice in treating cardiovascular diseases.

Li H, Sureda A, Devkota HP, Pittalà V, Barreca D, Silva AS, Tewari D, Xu S, Nabavi SM.

Biotechnol Adv. 2019 Feb 1. pii: S0734-9750(19)30010-2. doi: 10.1016/j.biotechadv.2019.01.010. [Epub ahead of print] Review.

PMID:
30716389
9.

Collateral sensitivity of natural products in drug-resistant cancer cells.

Efferth T, Saeed MEM, Kadioglu O, Seo EJ, Shirooie S, Mbaveng AT, Nabavi SM, Kuete V.

Biotechnol Adv. 2019 Jan 29. pii: S0734-9750(19)30009-6. doi: 10.1016/j.biotechadv.2019.01.009. [Epub ahead of print] Review.

PMID:
30708024
10.

Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.

Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S.

Pharmacol Res. 2019 Mar;141:466-480. doi: 10.1016/j.phrs.2019.01.014. Epub 2019 Jan 11. Review.

PMID:
30639373
11.

Down syndrome: Neurobiological alterations and therapeutic targets.

Vacca RA, Bawari S, Valenti D, Tewari D, Nabavi SF, Shirooie S, Sah AN, Volpicella M, Braidy N, Nabavi SM.

Neurosci Biobehav Rev. 2019 Mar;98:234-255. doi: 10.1016/j.neubiorev.2019.01.001. Epub 2019 Jan 4. Review.

PMID:
30615933
12.

Targeting STATs in neuroinflammation: The road less traveled!

Nabavi SM, Ahmed T, Nawaz M, Devi KP, Balan DJ, Pittalà V, Argüelles-Castilla S, Testai L, Khan H, Sureda A, de Oliveira MR, Vacca RA, Xu S, Yousefi B, Curti V, Daglia M, Sobarzo-Sánchez E, Filosa R, Nabavi SF, Majidinia M, Dehpour AR, Shirooie S.

Pharmacol Res. 2019 Mar;141:73-84. doi: 10.1016/j.phrs.2018.12.004. Epub 2018 Dec 11. Review.

PMID:
30550953
13.

Plant derived glycosides with α-glucosidase inhibitory activity: current standing and future prospects.

Khan H, Amin S, Tewari D, Nabavi SM, Atanasov AG.

Endocr Metab Immune Disord Drug Targets. 2018 Nov 27. doi: 10.2174/1871530319666181128104831. [Epub ahead of print]

PMID:
30484413
14.

Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering.

Nabavi SM, Šamec D, Tomczyk M, Milella L, Russo D, Habtemariam S, Suntar I, Rastrelli L, Daglia M, Xiao J, Giampieri F, Battino M, Sobarzo-Sanchez E, Nabavi SF, Yousefi B, Jeandet P, Xu S, Shirooie S.

Biotechnol Adv. 2018 Nov 17. pii: S0734-9750(18)30181-2. doi: 10.1016/j.biotechadv.2018.11.005. [Epub ahead of print] Review.

PMID:
30458225
15.

MiRNAs and inflammatory bowel disease: An interesting new story.

Moein S, Vaghari-Tabari M, Qujeq D, Majidinia M, Nabavi SM, Yousefi B.

J Cell Physiol. 2019 Apr;234(4):3277-3293. doi: 10.1002/jcp.27173. Epub 2018 Nov 11. Review.

PMID:
30417350
16.

Engineering stilbene metabolic pathways in microbial cells.

Jeandet P, Sobarzo-Sánchez E, Clément C, Nabavi SF, Habtemariam S, Nabavi SM, Cordelier S.

Biotechnol Adv. 2018 Dec;36(8):2264-2283. doi: 10.1016/j.biotechadv.2018.11.002. Epub 2018 Nov 9. Review.

PMID:
30414914
17.

Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.

Vazirian M, Nabavi SM, Jafari S, Manayi A.

Food Chem Toxicol. 2018 Dec;122:69-79. doi: 10.1016/j.fct.2018.09.079. Epub 2018 Oct 2. Review.

PMID:
30290216
18.

Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems.

Hajialyani M, Tewari D, Sobarzo-Sánchez E, Nabavi SM, Farzaei MH, Abdollahi M.

Int J Nanomedicine. 2018 Sep 3;13:5023-5043. doi: 10.2147/IJN.S174072. eCollection 2018. Review.

19.

Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective.

Farzaei MH, Bahramsoltani R, Abbasabadi Z, Braidy N, Nabavi SM.

J Cell Physiol. 2019 Mar;234(3):2447-2459. doi: 10.1002/jcp.27289. Epub 2018 Sep 6. Review.

PMID:
30187490
20.

The natural plant compound carvacrol as an antimicrobial and anti-biofilm agent: mechanisms, synergies and bio-inspired anti-infective materials.

Marchese A, Arciola CR, Coppo E, Barbieri R, Barreca D, Chebaibi S, Sobarzo-Sánchez E, Nabavi SF, Nabavi SM, Daglia M.

Biofouling. 2018 Jul;34(6):630-656. doi: 10.1080/08927014.2018.1480756. Epub 2018 Aug 1. Review.

PMID:
30067078

Supplemental Content

Loading ...
Support Center